chr4-88750594-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014883.4(FAM13A):āc.1770C>Gā(p.Asp590Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,120 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014883.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM13A | NM_014883.4 | c.1770C>G | p.Asp590Glu | missense_variant | 15/24 | ENST00000264344.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM13A | ENST00000264344.10 | c.1770C>G | p.Asp590Glu | missense_variant | 15/24 | 5 | NM_014883.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152198Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250316Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135478
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461804Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727202
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152316Hom.: 1 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2023 | The c.1770C>G (p.D590E) alteration is located in exon 15 (coding exon 15) of the FAM13A gene. This alteration results from a C to G substitution at nucleotide position 1770, causing the aspartic acid (D) at amino acid position 590 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at